Skip to main content
. 2019 Nov 21;9:98. doi: 10.1186/s13550-019-0564-z

Fig. 4.

Fig. 4

As an example a SPECT/CT image (supine position) of a mouse bearing a BT474 tumor (a), 48 h after injection of 30 μg [111In]In-DTPA-trastuzumab-IRDye800CW, showing high uptake in the tumor. Fluorescence images before and after resection of the tumor (b, c), with a selected epi-fluorescence scale of 300–1000 counts. *Implanted estradiol pellet